# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION MEMORANDUM ASSAY ONLY TEMPLATE

Immunalysis Barbiturates Urine Enzyme Immunoassay Immunalysis Multi-Drug Calibrators

# G. Regulatory Information:

1. Regulation section:

21 CFR 862.3150 Barbiturate test system   
21 CFR 862.3200, Clinical toxicology calibrator

2. Classification: Class II

3. Product code:

DIS DKB

4. Panel: Toxicology (91)

# H. Intended Use:

1. Intended use(s): Refer to Indications for Use below

2. Indication(s) for use:

Immunalysis Barbiturates Urine Enzyme Immunoassay

The Immunalysis Barbiturates Urine Enzyme Immunoassay is a homogeneous enzyme immunoassay with a cutoff of $2 0 0 ~ \mathrm { { n g / m L } }$ . The assay is intended for use in laboratories for the qualitative and semi-quantitative analysis of Barbiturates in human urine with automated clinical chemistry analyzers. This assay is calibrated against Secobarbital. This in vitro diagnostic device is for prescription use only.

The semi-quantitative mode is for purposes of enabling laboratories to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as Gas Chromatography/ Mass Spectrometry (GC-MS) or Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) or permitting laboratories to establish quality control procedures.

The Immunalysis Barbiturates Urine Enzyme Immunoassay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. GC-MS or LC-MS/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

lmmunalysis Multi-Drug Calibrators:

The lmmunalysis Multi-Drug Calibrators are intended for in vitro diagnostic use for the calibration of assays for the following analytes: Benzoylecgonine, Methamphetamine, Morphine, PCP, Secobarbital and Oxazepam. The calibrators are designed for prescription use with immunoassays.

3. Special conditions for use statement(s): For prescription use only.

4. Special instrument requirements: Performance data was obtained using the Beckman AU400e clinical chemistry analyzer.

# I. Device Description:

The Immunalysis Barbiturates Urine Enzyme Immunoassay Kit reagents are provided as ready to use liquids and consist of the following reagents:

The Antibody/ Substrate Reagent (Reagent A; 25, 100, or $5 0 0 ~ \mathrm { m L }$ ) contains a recombinant antibody to Secobarbital, a mouse monoclonal antibody to Secobarbital, glucose-6-phosphate (G6P) and nicotinamide adenine dinucleotide (NAD) in HEPES buffer with Sodium Azide as a preservative.   
The Enzyme Conjugate Reagent (Reagent E; 25, 100, or $5 0 0 ~ \mathrm { m L }$ ) contains glucose-6- phosphate dehydrogenase (G6PDH) labeled with Barbiturates in HEPES buffer with Sodium Azide as a preservative.

Immunalysis Multi-Drug Calibrators are provided separately, as five individual, liquid ready-to use drug levels ( $1 5 ~ \mathrm { m L }$ or $2 5 ~ \mathrm { m L }$ ).

# J. Substantial Equivalence Information:

1. Predicate device name(s): DRI Barbiturates EIA Assay

2. Predicate 510(k) number(s): k955928

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities - Reagent</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Candidate Device Immunalysis BarbituratesUrine Enzyme Immunoassay</td><td colspan="1" rowspan="1">Predicate Device  DRIBarbiturates EIA Assayk955928</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">For the qualitative andsemiquantitativedetermination of thepresence of Barbiturates inhuman urine</td></tr><tr><td colspan="1" rowspan="1">Assay cutoff</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">200 ng/mL</td></tr><tr><td colspan="1" rowspan="1">Calibrator compound</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Secobarbital</td></tr><tr><td colspan="1" rowspan="1">Assay type</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Homogeneous enzymeimmunoassay, qualitativeand semi-quantitative</td></tr><tr><td colspan="1" rowspan="1">Storage conditions</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">2° -8°C</td></tr><tr><td colspan="3">Differences - Reagent</td></tr><tr><td>Item</td><td>Candidate Device Immunalysis Barbiturates Urine Enzyme</td><td>Predicate Device  DRI Barbiturates EIA Assay k955928</td></tr><tr><td>Calibrators</td><td>Immunoassay Provided separately</td><td>Provided with assay</td></tr><tr><td>Controls</td><td>Provided separately</td><td>Provided with assay</td></tr><tr><td>Antibody type</td><td>Recombinant and mouse monoclonal</td><td>Mouse monoclonal</td></tr></table>

<table><tr><td colspan="3">Similarities - Calibrators</td></tr><tr><td>Item</td><td>Candidate Device Immunalysis Multi-Drug Calibrators (MDC)</td><td>Predicate Device — Calibrators included with DRI Barbiturates EIA Assay k955928</td></tr><tr><td>Calibrator drug</td><td>Same</td><td>Secobarbital</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences - Calibrators</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Candidate Device —Immunalysis Negative andMulti-Drug Calibrators(MDC)</td><td rowspan=1 colspan=1>Predicate Device —Calibrators included withDRI Barbiturates EIAAssay k955928</td></tr><tr><td rowspan=1 colspan=1>Calibrator Levels</td><td rowspan=1 colspan=1>Calibrator levels at 0100, 200, 500 and 1000ng/mL</td><td rowspan=1 colspan=1>Calibrator levels at 0, 200,and 1000 ng/mL</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

C CLSI EP5-A3: Evaluation of Precision Performance of Quantitative Measurement Methods   
· CLSI EP 7-A3: Interference Testing in Clinical Chemistry.   
· ISO 14971 Second edition 2007-03-01, Medical devices – application of risk management to medical devices EN ISO 14971:2012 Medical devices. Application of risk management to medical devices

# L. Test Principle:

This assay uses a recombinant and a mouse monoclonal antibody, both directed against Secobarbital. The assay is based on the competition of Barbiturates labeled enzyme glucose6-phosphate dehydrogenase (G6PDH) and the free drug in the urine sample for the fixed amount of antibody binding sites. In the absence of the free drug in the sample, the antibody binds the drug enzyme conjugate and enzyme activity is inhibited. This creates a dose response relationship between drug concentration in the urine and enzyme activity. The enzyme G6PDH activity is determined at $3 4 0 \mathrm { n m }$ spectrophotometrically by the conversion of Nicotinamide Adenine Dinucleotide (NAD) to NADH.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

A precision/cutoff characterization study was performed over 20 days, with two runs per day in duplicate $\scriptstyle ( \mathrm { n } = 8 0 )$ ) on calibrators (100 and $2 0 0 ~ \mathrm { { n g / m L } }$ ), controls (150 and $2 5 0 ~ \mathrm { n g / m L }$ and drug-free negative urine samples spiked with secobarbital to concentrations of 50, 300, 350, and $4 0 0 ~ \mathrm { { n g / m L } }$ . The spiked concentrations were confirmed by mass spectrometry (MS). The concentrations and results of the study are summarized below:

<table><tr><td rowspan=1 colspan=4>Qualitative Analysis</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1># of determinations</td><td rowspan=1 colspan=1>Result</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg / 0 pos</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg / 0 pos</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg0 pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg0 pos</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>33 neg47 pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg/80 pos</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg80 pos</td></tr><tr><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg80pos</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg /80pos</td></tr></table>

<table><tr><td rowspan=1 colspan=4>Semi -quantitative Analysis</td></tr><tr><td rowspan=1 colspan=1>Concentration(ng/mL)</td><td rowspan=1 colspan=1>% of cutoff</td><td rowspan=1 colspan=1># of determinations</td><td rowspan=1 colspan=1>Result</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg / 0 pos</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg / 0 pos</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg/0 pos</td></tr><tr><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 neg/ 0 pos</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>23 neg57 pos</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg80 pos</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg80 pos</td></tr><tr><td rowspan=1 colspan=1>350</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg80pos</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>0 neg /80 pos</td></tr></table>

# b. Linearity/assay reportable range:

A linearity study in the semi-quantitative mode was conducted by spiking a drug-free urine pool with a high concentration of Secobarbital and generating serial dilutions to achieve concentrations ranging from $0 \mathrm { n g / m L }$ to $1 1 0 0 ~ \mathrm { { n g / m L } }$ . The $0 \mathrm { n g / m L }$ sample utilized drug free urine and was not achieved through serial dilution. Each concentration was tested in triplicate and drug recovery calculated using the mean concentration of the replicates. The results are summarized below:

<table><tr><td rowspan=1 colspan=3>Linearity/Recovery</td></tr><tr><td rowspan=1 colspan=1>Expected Concentration(ng/mL)</td><td rowspan=1 colspan=1>Mean Concentration(ng/mL)</td><td rowspan=1 colspan=1>Recovery (%)</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-0.6</td><td rowspan=1 colspan=1>n/a</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>93.2</td><td rowspan=1 colspan=1>93.2</td></tr><tr><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>196.0</td><td rowspan=1 colspan=1>98.0</td></tr><tr><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>314.7</td><td rowspan=1 colspan=1>104.9</td></tr><tr><td rowspan=1 colspan=1>400</td><td rowspan=1 colspan=1>418.1</td><td rowspan=1 colspan=1>104.5</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>487.9</td><td rowspan=1 colspan=1>97.6</td></tr><tr><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>604.1</td><td rowspan=1 colspan=1>100.7</td></tr><tr><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>724.2</td><td rowspan=1 colspan=1>103.5</td></tr><tr><td rowspan=1 colspan=1>800</td><td rowspan=1 colspan=1>819.3</td><td rowspan=1 colspan=1>102.4</td></tr><tr><td rowspan=1 colspan=1>900</td><td rowspan=1 colspan=1>891.2</td><td rowspan=1 colspan=1>99.0</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>968.7</td><td rowspan=1 colspan=1>96.9</td></tr><tr><td rowspan=1 colspan=1>1100</td><td rowspan=1 colspan=1>981.8</td><td rowspan=1 colspan=1>89.3</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability

The secobarbital in the calibrator is traceable to a commercially available secobarbital solution. This standard is diluted with synthetic negative urine to make the calibrators at the desired concentrations. The concentrations are confirmed by Gas Chromatography/Mass Spectrometry Analysis (GC/MS) and/or Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS).

Value Assignment/Expected Values

Calibrators are manufactured and tested by mass spectrometry. The negative calibrator is a processed, drug free urine matrix. The negative calibrator is compared to a reference negative standard to ensure that it is free of analyte. The non-zero calibrators are prepared by spiking a known concentration of secobarbital into a negative calibrator matrix. If any of the analytes are not within the acceptable range, as measured by mass spectrometry,then the calibrator is adjusted and re-tested. Values are assigned to the calibrators once the mass spectrometry results are within the acceptable ranges.

# Calibrator Stability

Stability protocols and acceptance criteria for the calibrators were reviewed and found to be acceptable. The sponsor claims that when stored at $2 - 8 ^ { \mathrm { { o } } } \mathrm { { C } }$ calibrators and controls are stable for one year. The sponsor claims that once opened, the calibrators and controls are stable for 60 days when stored at $2 - 8 ^ { \mathrm { o } } \mathrm { C }$ .

d. Detection limit: Not applicable.

e. Analytical specificity:

Structurally related compounds

The sponsor performed cross-reactivity studies in both qualitative and semiquantitative modes by spiking various barbiturates or structurally related compounds into drug free urine at levels that will yield a result that is equivalent to the assay cutoff $( 2 0 0 ~ \mathrm { n g / m L } )$ . The results were the same for the qualitative and semiquantitative modes and are summarized below:

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>ConcentrationTested (ng/mL)</td><td rowspan=1 colspan=1>Cross-Reactivity (%)</td></tr><tr><td rowspan=1 colspan=1>Secobarbital</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Allobarbital</td><td rowspan=1 colspan=1>690</td><td rowspan=1 colspan=1>29.0</td></tr><tr><td rowspan=1 colspan=1>Alphenal</td><td rowspan=1 colspan=1>190</td><td rowspan=1 colspan=1>105.3</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Aprobarbital</td><td rowspan=1 colspan=1>700</td><td rowspan=1 colspan=1>28.6</td></tr><tr><td rowspan=1 colspan=1>Barbital</td><td rowspan=1 colspan=1>9,000</td><td rowspan=1 colspan=1>2.2</td></tr><tr><td rowspan=1 colspan=1>Butabarbital</td><td rowspan=1 colspan=1>510</td><td rowspan=1 colspan=1>39.2</td></tr><tr><td rowspan=1 colspan=1>Butalbital</td><td rowspan=1 colspan=1>290</td><td rowspan=1 colspan=1>69.0</td></tr><tr><td rowspan=1 colspan=1>Butobarbital</td><td rowspan=1 colspan=1>190</td><td rowspan=1 colspan=1>105.3</td></tr><tr><td rowspan=1 colspan=1>Cyclopentobarbital</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>100.0</td></tr><tr><td rowspan=1 colspan=1>Hexobarbital</td><td rowspan=1 colspan=1>70,000</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Mephobarbital</td><td rowspan=1 colspan=1>65,000</td><td rowspan=1 colspan=1>0.3</td></tr><tr><td rowspan=1 colspan=1>Pentobarbital</td><td rowspan=1 colspan=1>420</td><td rowspan=1 colspan=1>47.6</td></tr><tr><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1>460</td><td rowspan=1 colspan=1>43.5</td></tr><tr><td rowspan=1 colspan=1>Phenytoin</td><td rowspan=1 colspan=1>100,000</td><td rowspan=1 colspan=1>&lt;0.2</td></tr><tr><td rowspan=1 colspan=1>Talbutal</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>90.9</td></tr><tr><td rowspan=1 colspan=1>Thiopental</td><td rowspan=1 colspan=1>3,700</td><td rowspan=1 colspan=1>5.4</td></tr></table>

# Non-structurally related compounds

Potential interference from non-structurally related drugs and metabolites was evaluated in the qualitative and semi-quantitative modes by spiking these compounds into drug free urine containing secobarbital at $\pm 2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff (150 $\mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ respectively). The results were the same for the qualitative and semi-quantitative modes and are summarized below:

<table><tr><td colspan="4" rowspan="1">Structurally Unrelated Compounds (for 200 ng/mL cutoff)</td></tr><tr><td colspan="1" rowspan="2">Compound</td><td colspan="1" rowspan="2">ConcentrationTested(ng/mL)</td><td colspan="1" rowspan="1">-25%Cutoff(150)ng/mL)</td><td colspan="1" rowspan="1">+25%Cutoff((250)ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">4-Bromo-2,5,Dimethoxyphenethylamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicyclic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetylcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">6-Acetylmorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">7-Aminoclonazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">7-Aminoflunitrazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">7-Aminonitrazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S-(+) Amphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Benzylpiperazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Buprenorphrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carbamazepine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Carisoprodol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">cis-Tramadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Clozapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cotinine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Demoxepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Desalkyflurazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="2">Compound</td><td colspan="1" rowspan="2">ConcentrationTested(ng/mL)</td><td colspan="1" rowspan="1">-25%Cutoff(150)ng/mL)</td><td colspan="1" rowspan="1">+25%Cutoff(250ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Dehydronorketamine</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Delta-9-THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">1R,2S(-)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">1S,2R(+)-Ephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ethyl glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fentanyl</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">11-hydroxy-delta-9-THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lamotrignine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Levorphanol tartrate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lidocaine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="2">Compound</td><td colspan="1" rowspan="2">ConcentrationTested(ng/mL)</td><td colspan="1" rowspan="1">-25%Cutoff(150ng/mL)</td><td colspan="1" rowspan="1">+25%Cutoff(250ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">Lorazepam Glucuronide</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">LSD</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">(+)-MDA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">MDEA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">MDMA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S(+)-Methamphetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methaquolone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methoxetamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methylone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Methylphenidate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Morphine-6-glucuronide</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">N-desmethyltapentadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">11-nor-9 carboxy THC</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="2">Compound</td><td colspan="1" rowspan="2">ConcentrationTested(ng/mL)</td><td colspan="1" rowspan="1">-25%CCutoff(150)ng/mL)</td><td colspan="1" rowspan="1">+25%Cutoff(250ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norketamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpropoxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Norpseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Olanzapine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PCP</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Pentazocine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenylephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Phenylpropanolamine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">PMA</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Prazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Proproxyphene</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Propranolol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">R,R(-)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">S,S(+)-Pseudoephedrine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ranitidine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ritalinic Acid</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Salicylic Acid</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Sufentanil Citrate</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Tapentadol</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Theophylline</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="2">Compound</td><td colspan="1" rowspan="2">ConcentrationTested(ng/mL)</td><td colspan="1" rowspan="1">-25%Cutoff(150ng/mL)</td><td colspan="1" rowspan="1">+25%Cutoff(250ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Result</td><td colspan="1" rowspan="1">Result</td></tr><tr><td colspan="1" rowspan="1">Trifluoromethylphenyl-piperazine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Venlafaxine</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Verapamil</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Zolpidem Tartrate</td><td colspan="1" rowspan="1">100,000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr></table>

Endogenous compounds. Potential interference from endogenous compounds was evaluated in the qualitative and semi-quantitative modes by spiking these compounds into drug free urine containing secobarbital at $\pm 2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff (150 $\mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). The results were the same for the qualitative and semi-quantitative modes and are summarized below:

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Concentration Tested(ng/mL)</td><td rowspan=1 colspan=1>-25%Cutoff(150ng/mL)</td><td rowspan=1 colspan=1>+25%Cutoff(250ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>0.002 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>0.01 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>γ-Globulin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>0.115 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Human Serum Albumin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>0.1 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>0.0075 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Sodium Azide</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Sodium Chloride</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>SodiumFluoride</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr></table>

Boric Acid. Boric Acid was also evaluated, and at a concentration of $1 \% \mathrm { ~ w ~ } / \mathrm { v }$ was found to cause false negative results at both the $+ 2 5 \%$ and $+ 5 0 \%$ $2 5 0 ~ \mathrm { n g / m L }$ and 300 $\mathrm { { n g / m L } }$ , respectively) at the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff in both the qualitative and semiquantitative modes. The following statement is provided in the limitations section of the labeling: “Boric Acid at $1 \%$ w/v may cause false negative results. Boric Acid is not recommended as a preservative for urine”.

pH and Specific Gravity. To evaluate potential interference from the pH of urine, device performance in the qualitative and semi-quantitative modes was tested using a range of urine $\mathsf { p H }$ values (3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0 and 11.0). All test samples were prepared in drug free urine containing secobarbital at $\pm 2 5 \%$ of the 200 $\mathrm { n g / m L }$ cutoff ( $1 5 0 ~ \mathrm { n g / m L }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). No positive or negative interference was observed at urine $\mathrm { p H }$ values ranging from 3.0 to 11.0 for the qualitative and semi-quantitative modes.

To evaluate potential interference from the specific gravity of urine, device performance in the qualitative and semi-quantitative modes was tested using a range of urine specific gravity values (1.000, 1.002, 1.005, 1.010, 1.015, 1.020, 1.025 and 1.030). All test samples were prepared in drug free urine containing secobarbital at $\pm$ $2 5 \%$ of the $2 0 0 ~ \mathrm { { n g / m L } }$ cutoff ( $1 5 0 ~ \mathrm { { n g / m L } }$ and $2 5 0 ~ \mathrm { { n g / m L } }$ , respectively). No positive or negative interference was observed at urine specific gravity values ranging from 1.000 to 1.030 for the qualitative and semi-quantitative modes.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration of $2 0 0 ~ \mathrm { { n g / m L } }$ is described in the precision section, M.1.a. above.

2. Comparison studies:

# a. Method comparison with predicate device:

The method comparison study was performed in-house using unaltered, clinical urine samples obtained from clinical testing laboratories. A total of 96 samples were analyzed. Each sample was run in singlicate on a Beckman Coulter AU400e Chemistry Analyzer and the result was compared to that obtained by liquid chromatography/mass spectroscopy (LC/MS-MS). The results were the same for the qualitative and semi-quantitative modes and are summarized below.

Candidate Device Results vs. stratified LC/MS-MS Values   

<table><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative bythe predicatedevice or lessthan half thecutoffconcentrationby GC/MSanalysis</td><td rowspan=1 colspan=1>Near CutoffNegative(Between50% belowthe cutoff andthe cutoffconcentration)</td><td rowspan=1 colspan=1>Near CutoffPositive(Between thecutoff and50% abovethe cutoffconcentration)</td><td rowspan=1 colspan=1>High Positive(greater than50% abovethe cutoffconcentration)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>44</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

$\%$ Agreement among positives is $5 2 / 5 2 = 1 0 0 \%$ $\%$ Agreement among negatives is $4 4 / 4 4 = 1 0 \%$ $b$ . Matrix comparison: Not applicable. Urine is the only claimed matrix for the candidate device.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.